DC-SIGN (CD209) gene promoter polymorphisms in a Brazilian population and their association with human T-cell lymphotropic virus type 1 infection

Journal of General Virology

Volumn 90, Issue 4, 2009, Pages 927-934

  Kashima, Simone ^a   Rodrigues, Evandra Strazza ^a   Azevedo, Rochele ^a   da Cruz Castelli, Erick ^a   Mendes Junior, Celso Teixeira ^a   Yoshioka, France Keiko Nascimento ^a   da Silva, Israel Tojal ^a   Takayanagui, Osvaldo Massaiti ^a   Covas, Dimas Tadeu ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN;

ADULT; AMERICAN INDIAN; ARTICLE; ASIAN; BRAZIL; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; VIRUS TRANSMISSION; AGED; CLASSIFICATION; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PATHOGENICITY; RACE;

HUMAN T-LYMPHOTROPIC VIRUS 1;

ADULT; AGED; BRAZIL; CELL ADHESION MOLECULES; CONTINENTAL POPULATION GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LECTINS, C-TYPE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; YOUNG ADULT;

EID: 65549097628     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.008367-0     Document Type: Article

References (42)

1. Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, O., Corbí, A. L. & Delgado, R. (2002). C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 76, 6841-6844.
2. Banchereau, J. & Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392, 245-252.
3. Barreiro, L. B., Neyrolles, O., Babb, C. L., Tailleux, L., Quach, H., McElreavey, K., Helden, P. D., Hoal, E. G., Gicquel, B. & Quintana-Murci, L. (2006a). Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med 3, e20.
4. Barreiro, L. B., Quach, H., Krahenbuhl, J., Khaliq, S., Mohyuddin, A., Mehdi, S. Q., Gicquel, B., Neyrolles, O. & Quintana-Murci, L. (2006b). DC-SIGN interacts with Mycobacterium leprae but sequence variation in this lectin is not associated with leprosy in the Pakistani population. Hum Immunol 67, 102-107.
5. Barreiro, L. B., Neyrolles, O., Babb, C. L., Van Helden, P. D., Gicquel, B., Hoal, E. G. & Quintana-Murci, L. (2007). Length variation of DC-SIGN and L-SIGN neck-region has no impact on tuberculosis susceptibility. Hum Immunol 68, 106-112.
6. Boily-Larouche, G., Zijenah, L. S., Mbizvo, M., Ward, B. J. & Roger, M. (2007). DC-SIGN and DC-SIGNR genetic diversity among different ethnic populations: Potential implications for pathogen recognition and disease susceptibility. Hum Immunol 68, 523-530.
7. Ceccaldi, P. E., Delebecque, F., Prevost, M. C., Moris, A., Abastado, J. P., Gessain, A., Schwartz, O. & Ozden, S. (2006). DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells. J Virol 80, 4771-4780.
8. Ewing, B. & Green, P. (1998). Base-calling of automated sequencer traces using Phred. II. Error probabilities. Genome Res 8, 186-194.
9. Ewing, B., Hillier, L., Wendl, M. C. & Green, P. (1998). Base-calling of automated sequencer traces using Phred. I. Accuracy assessment. Genome Res 8, 175-185.
10. Excoffier, L. & Slatkin, M. (1995). Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12, 921-927.
11. Excoffier, L. & Slatkin, M. (1998). Incorporating genotypes of relatives into a test of linkage disequilibrium. Am J Hum Genet 62, 171-180.
12. Excoffier, L., Laval, G. & Schneider, S. (2005). Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform Online 1, 47-50.
13. Gessain, A., Barin, F., Vernant, J. C., Gout, O., Maurs, L., Calender, A. & de Thé, G. (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2, 407-410.
14. Gómez, L. M., Anaya, J. M., Sierra-Filardi, E., Cadena, J., Corbí, A. & Martín, J. (2006). Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis. Hum Immunol 67, 808-811.
15. Guo, S. W. & Thompson, E. A. (1992). Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48, 361-372.
16. Halary, F., Amara, A., Lortat-Jacob, H., Messerle, M., Delaunay, T., Houlès, C., Fieschi, F., Arenzana-Seisdedos, F., Moreau, J. F. & Déchanet-Merville, J. (2002). Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 17, 653-664.
17. Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K. I., Shirakawa, S. & Miyoshi, I. (1981). Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A 78, 6476-6480.
18. + T cells. Nat Med 14, 429-436.
19. Koizumi, Y., Kageyama, S., Fujiyama, Y., Miyashita, M., Lwembe, R., Ogino, K., Shioda, T. & Ichimura, H. (2007). RANTES -28G delays and DC-SIGN -139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs. AIDS Res Hum Retroviruses 23, 713-719.
20. LaGrenade, L., Hanchard, B., Fletcher, V., Cranston, B. & Blattner, W. (1990). Infective dermatitis of Jamaican children: A marker for HTLV-I infection. Lancet 336, 1345-1347.
21. Marth, G. T., Korf, I., Yandell, M. D., Yeh, R. T., Gu, Z., Zakeri, H., Stitziel, N. O., Hillier, L., Kwok, P. Y. & Gish, W. R. (1999). A general approach to single-nucleotide polymorphism discovery. Nat Genet 23, 452-456.
22. Martin, M. P., Lederman, M. M., Hutcheson, H. B., Goedert, J. J., Nelson, G. W., van kooyk, Y., Detels, R., Buchbinder, S., Hoots, K. & other authors (2004). Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol 78, 14053-14056.
23. Mochizuki, M.,Watanabe, T., Yamaguchi, K., Tajima, K., Yoshimura, K., Nakashima, S., Shirao, M., Araki, S., Miyata, N. & other authors (1992). Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies. J Infect Dis 166, 943-944.
24. Morgan, O. S., Rodgers-Johnson, P., Mora, C. & Char, G. (1989). HTLV-1 and polymyositis in Jamaica. Lancet 2, 1184-1187.
25. Nickerson, D. A., Tobe, V. O. & Taylor, S. L. (1997). PolyPhred: Automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 25, 2745-2751.
26. Núñez, C., Rueda, B., Martínez, A., Maluenda, C., Polanco, I., López-Nevot, M. A., Ortega, E., Sierra, E., Gómez de la Concha, E. & other authors (2006). A functional variant in the CD209 promoter is associated with DQ2-negative celiac disease in the Spanish population. World J Gastroenterol 12, 4397-4400.
27. Olesen, R., Wejse, C., Velez, D. R., Bisseye, C., Sodemann, M., Aaby, P., Rabna, P., Worwui, A., Chapman, H. & other authors (2007). DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun 8, 456-467.
28. Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M. & Tara, M. (1986). HTLV-I associated myelopathy, a new clinical entity. Lancet 1, 1031-1032.
29. Plancoulaine, S., Gessain, A., Tortevoye, P., Boland-Auge, A., Vasilescu, A., Matsuda, F. & Abel, L. (2006). A major susceptibility locus for HTLV-1 infection in childhood maps to chromosome 6q27. Hum Mol Genet 15, 3306-3312.
30. Pociot, F., Molvig, J., Wogensen, L., Worsaae, H. & Nerup, J. (1992). A TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 22, 396-402.
31. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D. & Gallo, R. C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77, 7415-7419.
32. Raymond, M. & Rousset, F. (1995a). GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 86, 248-249.
33. Raymond, M. & Rousset, F. (1995b). An exact test for population differentiation. Evolution 49, 1280-1283.
34. Sakuntabhai, A., Turbpaiboon, C., Casadé mont, I., Chuansumrit, A., Lowhnoo, T., Kajaste-Rudnitski, A., Kalayanarooj, S. M., Tangnararatchakit, K., Tangthawornchaikul, N. & other authors (2005). A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 37, 507-513.
35. Soilleux, E. J., Morris, L. S., Leslie, G., Chehimi, J., Luo, Q., Levroney, E., Trowsdale, J., Montaner, L. J., Doms, R. W. & other authors (2002). Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 71, 445-457.
36. Stephens, M., Smith, N. J. & Donnelly, P. (2001). A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68, 978-989.
37. Tailleux, L., Schwartz, O., Herrmann, J. L., Pivert, E., Jackson, M., Amara, A., Legres, L., Dreher, D., Nicod, L. P. & other authors (2003). DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 197, 121-127.
38. Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, M. A., Pattanapanyasat, K., Sarasombath, S. & other authors (2003). DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197, 823-829.
39. Turner, D. M., Williams, D. M., Sankaran, D., Lazarus, M., Sinnott, P. J. & Hutchinson, I. V. (1997). An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24, 1-8.
40. Vannberg, F. O., Chapman, S. J., Khor, C. C., Tosh, K., Floyd, S., Jackson-Sillah, D., Crampin, A., Sichali, L., Bah, B. & other authors (2008). CD209 genetic polymorphism and tuberculosis disease. PLoS One 3, e1388.
41. Wichukchinda, N., Kitamura, Y., Rojanawiwat, A., Nakayama, E. E., Song, H., Pathipvanich, P., Auwanit, W., Sawanpanyalert, P., Iwamoto, A. & other authors (2007). The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection. AIDS Res Hum Retroviruses 23, 686-692.
42. Yoshida, M., Miyoshi, I. & Hinuma, Y. (1982). Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 79, 2031-2035.